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Abstract: This study intends to show the use of upconversion photoluminescence 
imaging to investigate the colonization and infection dynamics of a natural murine 
intestinal pathogen, Citrobacter rodentium (C.rodentium), which induces inflammation in 
mice. © 2019 The Author(s). 
OCIS codes: 170.2680, 170.3880, 170.6280 
Inflammatory Bowel Diseases (IBDs) including Crohn’s disease (CD) and ulcerative colitis 
(UC) are associated with the chronic inflammatory state of gastrointestinal tract. The exact 
causes of IBD are still unknown, however, the recent studies show that gut microbiota is a 
contributing factor to IBD [1]. Although the role of intestinal microbes in the development of 
IBD in animals is revealed, the interaction mechanisms between the host and these microbes are 
yet not precisely defined. To understand these interactions in vivo, C.rodentium infection model 
has been studied. C.rodentium is the most widely used model to study host-pathogen 
interactions as it shows high genetic similarities to human pathogens, including 
enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E.coli (EHEC) [2]. These 
pathogens are associated with the development of IBD in human. C.rodentium infection model 
has been studied by different in vivo imaging techniques, including fluorescence imaging (FI) 
and bioluminescence (BL) [3, 4]. FI employs custom designed fluorophores as contrast markers, 
whereas BL rely on genetically modified pathogen strains that are able to catalyse luciferin 
molecule by luciferase enzyme. However, using fluorescent probes in vivo studies has some 
limitations such as tissue autofluorescence, photobleaching and photodamage. In case of BL, the 
process is dependent on the metabolic state of the pathogen and the oxygen content in the 
environment (i.e. requires in vivo studies with blood circulation). In addition, it is not always 
possible to genetically engineer all types of bacteria for BL use. 
In this study, lanthanide based upconverting nanoparticles (Ln-UCNPs), a class of 
photoluminescent nanomaterials, are being exploited as labelling agent as well as contrast 
marker to visualise infection dynamics of C.rodentium. Ln-UCNP are promising candidates to 
overcome the aforementioned limitations of FI and BL. Ln-UCNPs are capable of photon 
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upconversion, i.e. the conversion of incoming photons with lower energy into emitted photons 
with higher energy. The photon upconversion is as a result of two or multiple sequential photon 
absorption and has anti-Stokes nature. In this work, near infra-red (NIR) laser light at 976nm is 
used as an excitation source and Ln-UCNPs emits upconverted photons at 804 nm, which also 
falls in NIR region. In NIR region, most of the tissue molecules have relatively low absorption 
and scattering coefficients, which results in higher light penetration depths, low 
autofluorescence, and high signal-noise ratio. Thereby, C.rodentium infected mice is labelled by 
means of Ln-UCNPs conjugated with anti C.rodentium antibody. 108-109 colony forming unit 
(CFU) of C.rodentium are orally administered to mice at different time points to quantify 
C.rodentium. The infection kinetics of C.rodentium is consisted of three distinct phases. Phase
one, from day 0 to day 3 is known as initiation of infection. Phase two is the peak of infection,
from day 7 to day 10. Third phase is known as resolution phase, begins after day 10, where
C.rodentium is cleared out from the host. Upconversion photoluminescence from C.rodentium
labelled with UNCP-antibody in mice is imaged by a custom modified commercial in vivo
imaging system (IVIS Lumina III, Perkin Elmer) through these three distinct phases. Herein, it
should be noted that major optical design modifications has been done to IVIS Lumina III to be
employed in NIR region. For this purpose, fiber coupled multi-mode NIR laser is attached to
the system. An optical cage has been designed particularly for this system, in which laser beam
is expanded and its spot size is selectively varied in a range from 5 mm up to 38 mm. Wisely
selected spectral filters are also placed to overexpose the existing camera inside the imaging
system. These Ln-UCNPs are chemically stable, i.e. no photo degradation is observed, as
compared to widely used organic fluorescent dyes. In addition, they show high photo stability,
no photoblinking is observed, as compared quantum dyes that are commonly used in FI.
Thereby, Ln-UNCPs can be used for studies in which long/repeated exposure times are
required, e.g. bacteria dissemination studies.
The upconversion photoluminescence is being compared with the BL in terms of light 
intensities. Moreover, the success of the bio-conjugation between UCNP-antibody and 
C.rodentium is being investigated. In addition the monitoring of the bacterial colonisation
dynamics inside the gut, biodistribution and pharmacokinetics of Ln-UCNPs are being studied.
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